Status:
COMPLETED
Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers
Lead Sponsor:
Galderma R&D
Conditions:
Facial Wrinkles
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to assess performance and tolerance as well as investigator and subject satisfaction linked to the global management of facial rejuvenation with a new range of hyaluronic acid...
Detailed Description
The range of fillers tested in this study includes 5 different hyaluronic acid dermal fillers: Emervel Touch, Emervel Classic, Emervel Deep, Emervel Volume and Emervel Lips. The study will last 6 mon...
Eligibility Criteria
Inclusion
- Seeking tissue augmentation treatment on the face,
- Presenting a score of 3 (Moderately deep wrinkle)or 4 (Deep wrinkle) on the Lemperle Rating Scale (LRS) of both nasolabial folds.
Exclusion
- At risk in term of precautions, warnings and contra-indication referred in the package insert of the study devices,
- Who underwent previous injection of permanent filler in the injected area.
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT01151436
Start Date
March 1 2010
End Date
February 1 2011
Last Update
March 10 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Galderma investigational site
Arras, France
2
Galderma investigational site
Nice, France
3
Galderma investigational site
Paris, France
4
Galderma investigational site
Berlin, Germany